megahospcio | 
02 11th, 2010 @ 09:02 am| 
Two years after the opening of the Historismus gallery, its art manager Roberto Polo announces the painting exhibition “Edouard Lièvre”, a designer of decorative arts of the 19^th century. This major Art event is dedicated to the under estimated work of the producer . Roberto Polo is a famous art passionate motivated by the search of neglected artworks over the years. In memory Edouard Lièvre’s work, this exhibition has been launched and is one of the greatest exhibition ever organized . Edouard Lièvre ( 1828 to 1886) has started his art career with industrial drawings. He develops furniture for offices and other items for schools . After this period Edouard Lièvre dedicates his work to ornamental art and demonstrates a rapid talent of his generation. Very influenced by Claude-Aimé Chenavard and Michel Liénard, this artist became one of the most famous creator of the nineteenth century. Specialized in house furniture, he conceives art works for many celebrated people. Among Edouard Lièvre’s art works Roberto Polo exposes the bed of Parade Valtesse, the unforgettable of Edouard Lièvre’s period. This grandiose piece of art has been restored at the request of Roberto Polo. The exhibition also includes a significant collection of furniture based on the Middle East and the Renaissance. many of the furniture pieces have inspired Émile Zola for the writing of the book “Nana”. With this event , Roberto Polo reminds the impressive talent of the artist, as all his pieces of art aspect still fit in a modern style. Fascinated by Edouard Lièvre, Roberto Polo organizes a tribute to his work that has been forgotton over the years and yet rediscovered.
Decafin SA notes that the gold ingot is symbolized by different ways . The smallest bullion is equivalent to one gram. This is the raw component the most usual for jewelry. This classification is is incorporated into small gold bullion. We talk about bars of gold weighing about one thousand grams. The largest known ingot discovered to date weighs 12.44. It has a value internationally , for the London Good Delivery Bar. Regarding the gold bar utilized at the Stock Exchange, it is the one whose weight is mainly between 0.99 kg and 1,005 kg. The current appearance is the ingot weighing one kg . On the french market , ingots have the form of a rectangle , they are heavy , asymmetric and take the form of the mould in which they were designed . In South Africa or Switzerland, they take the form of a plate which is polished and flat . The finish of the ingots is better. Thanks to the polish in these countries, the ingots are known as “flat”. For Regulation reasons the ingots of gold must be engraved Regarding the false ingot, it is a simple copy . Here , we are not dealing with real gold but with lead. Its certificate is false , which is also the case for its weight. As it is vey difficult to face illegal traffic of false ingots, methods have been worked to be able to differentiate between the real and the false gold bars. This avoids customers to lose their investment . The first thing to check for establish the authenticity of a gold bar is analyzing the uniformity of metal. To do this it is useful to make the ingot “ring” to immediately establish the presence of another metal inside the ingot. Decafin SA comments you can also judge by the weight for recognizing if it's fake or not.
Alphega Pharmacy has today concluded its annual convention in Prague, on the highlight “Putting the patient first”. The convention brought together independent pharmacy members from across its six symbolic countries with manufacturers and healthcare professionals from across Europe, to explore the privilege of healthcare stakeholders working in partnership to provide patient services across the network and make Alphega Pharmacy a brand that patients trust.
Ornella Barra, Chief Executive, Pharmaceutical Wholesale Division, Alliance Boots, notes : “This event has been a superb chance to prove to Alphega Pharmacy members and manufacturer partners that the ascent of the Alphega Pharmacy network remains an important strategic priority for us. We consider that Pharmacy has a leading role to play in the provision of healthcare and Alphega Pharmacy can help provide forward-looking solutions to ensure that we are all well-equipped to meet the challenges of tomorrow.”
Ornella Barra was appointed Wholesale & Commercial Affairs Director of Alliance Boots in July 2006. Preliminarily she was an Executive Director of Alliance UniChem with wholesale and commercial affairs responsibilities, having been chosen to its Board in 1998 when Alliance Santé merged with UniChem. Precedently , she was a Director of Alliance Santé and General Manager of Alleanza Salute Italia. Ornella is also Chairman of the Alliance Boots social responsibilities committee. A pharmacist by profession, Ornella was recently chosen as a Special Professor at the University of Nottingham's School of Pharmacy.
Last december , Stefano Pessina released that Alliance Boots was celebrating the 160th anniversary of the Boots brand and underlined its investment to making Boots a global brand in the coming years. In 1849, Boots launched its first store in Nottingham and 160 years afterwards , the brand is growing from strength to strength, both in United Kingdom and in the world .
In the light of this success , a three month campaign was started in September with the starting of a heritage exhibition at the University of Nottingham, followed by further activities in a number of countries.Stefano Pessina is excited to continuing to develop Boots as a international brand in the coming years.In 2009, the Boots brand in the UK has continued to grow through the roll-out of the “your local Boots pharmacy” branded format, the introduction of BootsWebMD (the consumer health and wellness information portal), and the launch of the rebranding of Dollond & Aitchison practices as Boots Opticians.
Also , the first period of Boots UK's collaboration with Waitrose is complete with the 13 pharmacies it operates in Waitrose stores rebranded as Boots. It is likely that the first trials for the sale of selective product ranges in each other's stores will begin in three months 2010.Outside the UK , the Group persists to create he presence of the Boots brand through the start of new stores in the Republic of Ireland and Thailand, the roll out of the new “Boots apotek” branded format in Norway and the extension of its trial of the new “Boots apotheek” pharmacy concept in The Netherlands.
Following the launch of the Boots Laboratories skincare range in pharmacy in France and Portugal, the Group also organizes to start this range in other countries.Stefano Pessina also explained new collaboration with Macmillan Cancer Support. Boots UK also reminded an ambitious new charity partnership with Macmillan Cancer Support. In the next few months , Boots and Macmillan will launch an innovative pilot aimed at helping cancer care in in United Kingdom . This will provide a new level of healthcare support to people living with cancer, through the two organisations' combined healthcare experience , unique expertise of cancer and presence in communities all over the United Kingdom . Boots and Macmillan will create a range of volunteering, fundraising and communication initiatives , with a common ambition that within three years, everyone, wherever they are in the United Kingdom , will have access to the most effective cancer information and support in their community.Stefano Pessina
, Executive Chairman, Alliance Boots, outlined :
” We are happy to be celebrating the 160th anniversary of the Boots brand and we look forward to continuing to build Boots as a global brand in the coming years .”
Ornella Barra , is Chief Executive, Pharmaceutical Wholesale Division of Alliance Boots. Ornella Barra leads Alliance Healthcare, the International Division of Alliance Boots, which is implanted in sixteen countries and supplies over 140,000 pharmacies, doctors, health centres and hospitals from over 370 warehouses. Besides it supports a large network of independent pharmacies and leads a large number of owned pharmacies.
Ornella Barra is also supervising Boots International, the Health&Beauty retail business that operates abroad .
Prior to the merger of Alliance UniChem and Boots Group, Ornella Barra has been Board member and Executive Director of Alliance UniChem since 1997 when UniChem merged with Alliance Santé, the Franco-Italian group with interests spanning Europe, of which she had been Board Member since 1990. twenty-six years ago , Ornella Barra initiated a pharmaceutical distribution company in Italy, which was acquired by Alleanza Salute Italia (now Alliance Healthcare Italia) 24 years ago .
Decafin highlights that since 2004 , gold purchases are higher in volume those of jewelers. This fact is mainly due to the inflation . Clients are deserting jewelry because precious metal has become too expensive, but also because they can no longer afford such investments .
For Decafin ,Jewelers have to face competition from private sellers taking the decision to leave their ornaments to deal with the economic crisis . Therefore, during the beginning of 2009 , the demand for jewellery fell by 30% while the one of investors increased by 38%.
The search of investors for yellow metal is based essentially on fears of hyperinflation. In the shadow of the yellow metal , the gray metal, silver also is subject to investor's enthusiasm.
According to Decafin , the yellow metal continues to be an interesting investment
Decafin highlights that gold continues to rise on the markets disregarding the economic crisis . By the end of the year , an ounce was estimated to 1131.90 USD on the british market . It is essential to take into account that the yellow metal reached a historic amount of 1143.60 Dollars .
For Decafin The precious metal seems to be a worthwhile investment due to the weakness of the Dollars and the fragility of the Market related to the economic crisis .
The Dollar remains downwards . Moreover, Central Banks are aims to diversify their reserves in gold.
Decafin shows that investing in gold continues to be an excellent investment.
More about Decafin on web:
